Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.070
-0.010 (-0.93%)
At close: May 22, 2026, 4:00 PM EDT
1.090
+0.020 (1.87%)
After-hours: May 22, 2026, 6:13 PM EDT
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $3.98 million as of May 22, 2026. Its market cap has increased by 33.44% in one year.
Market Cap
3.98M
Enterprise Value
-9.37M
1-Year Change
33.44%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $3.98M, a decrease of -95.60%. That is a compound annual growth rate of -43.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 3.98M | -15.98% |
| Dec 31, 2025 | 4.74M | 22.99% |
| Dec 31, 2024 | 3.85M | 22.21% |
| Dec 29, 2023 | 3.15M | -29.09% |
| Dec 30, 2022 | 4.45M | -93.24% |
| Dec 31, 2021 | 65.80M | -29.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mustang Bio | 4.79M |
| Cardio Diagnostics Holdings | 4.76M |
| Matinas BioPharma Holdings | 4.51M |
| Enveric Biosciences | 4.39M |
| Alzamend Neuro | 4.30M |
| Soligenix | 4.02M |
| VivoSim Labs | 3.94M |
| 60 Degrees Pharmaceuticals | 3.94M |